Evaluation of a low-intensity shockwave therapy for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial.
Ioannis MykoniatisDimitrios KalyvianakisFilimon ZilotisParaskevi KapoteliAgrippina FournarakiEvangelos PouliosDimitrios HatzichristouPublished in: Prostate cancer and prostatic diseases (2020)
LiST seems to be a safe and effective treatment option for CP/CPPS, considerably improving pain and quality of life. Lack of any side-effects, and the potential for repetition make LiST a promising treatment choice for CP/CPPS patients.
Keyphrases
- clinical trial
- double blind
- end stage renal disease
- open label
- chronic kidney disease
- ejection fraction
- newly diagnosed
- phase ii
- prognostic factors
- phase iii
- spinal cord injury
- pain management
- peritoneal dialysis
- neuropathic pain
- spinal cord
- climate change
- risk assessment
- replacement therapy
- human health
- decision making